Advertisement

Topics

Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

16:45 EDT 16 Apr 2018 | Boston Scientific

European Patent Office Revokes Edwards Lifesciences '550 Patent MARLBOROUGH, Mass., April 16, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it, along with several other opponents, successfully opposed Edwards Lifesciences Corporation's European patent EP 2,399,550 ('550) in the European Patent Office (EPO), resulting in a revocation of the patent.  The '550 patent was the only Edwards patent that Boston Scientific was found to infringe in the March 2017 German District Court litigation between the companies and is also the sole basis of Edwards' infringement action against Boston Scientific in Ireland. While Edwards has the right to appeal the E...

Original Article: Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences

NEXT ARTICLE

More From BioPortfolio on "Boston Scientific Prevails In European Patent Dispute With Edwards Lifesciences"

Advertisement
Quick Search
Advertisement
Advertisement